| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971961 | The Journal of Heart and Lung Transplantation | 2009 | 6 Pages |
Abstract
Elevated levels of circulating CD62e+ EMPs but not LMPs in PH patients prior to treatment are associated with adverse clinical events. Assessment of CD62e+ EMPs levels may represent a new tool for stratification of PH patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicolas MD, Christian MD, PhD, Vivian RN, Franca S. MD, MBA, Lauren Damon, Eddie J. MD, MPh, Dana MD, William MD, Teresa MD, Yerem MD,